Nephrogenic Diabetes Insipidus (DI)

Nephrogenic Diabetes Insipidus (DI) is a condition that affects the kidneys' ability to concentrate urine. It involves the renal system, specifically the kidney tubules, which become unresponsive to the hormone antidiuretic hormone (ADH). This leads to the production of large amounts of very dilute urine, causing excessive thirst and frequent urination. Because the kidneys cannot retain water properly, the body loses too much fluid, which can result in dehydration and electrolyte imbalances. The main health impact is the difficulty in maintaining proper fluid balance, which can affect overall well-being and daily functioning.

Nephrogenic Diabetes Insipidus (DI) is characterized by the kidney's inability to respond to antidiuretic hormone (ADH), despite normal or elevated ADH levels. The core pathology involves defective vasopressin V2 receptors or impaired function of the aquaporin-2 water channels in the collecting ducts, leading to impaired water reabsorption. It is commonly caused by genetic mutations in the AVPR2 gene (X-linked) or AQP2 gene (autosomal), or acquired due to drugs like lithium or chronic kidney disease. Clinically, it presents with polyuria, polydipsia, and risk of hypernatremia due to free water loss. Differentiation from central DI is critical, as nephrogenic DI does not improve with exogenous ADH administration. The condition is significant because it disrupts fluid homeostasis and can lead to severe dehydration if untreated.